Retail Opportunity Investments Corp. Reports Strong Third Quarter Results
Oct 25, 2016 20:05 pm UTC| Business
SAN DIEGO, Oct. 25, 2016 -- Retail Opportunity Investments Corp. (NASDAQ:ROIC) announced today financial and operating results for the three months and nine months ended September 30, 2016. HIGHLIGHTS $7.4mm of net...
HealthEquity Announces Closing of Secondary Offering of Common Stock
Oct 25, 2016 20:05 pm UTC| Business
DRAPER, Utah, Oct. 25, 2016 -- HealthEquity, Inc. (NASDAQ:HQY) announced today the closing of the previously announced secondary offering of shares of its common stock. Certain of HealthEquity’s stockholders have sold...
Prothena to Report Third Quarter 2016 Financial Results on November 1
Oct 25, 2016 20:05 pm UTC| Business
DUBLIN, Ireland, Oct. 25, 2016 -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, will...
Collegium Announces Proposed Public Offering of Common Stock
Oct 25, 2016 20:04 pm UTC| Business
CANTON, Mass., Oct. 25, 2016 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares in the offering are...
Cortland Bancorp Declares Quarterly Cash Dividend of $0.07 Per Share
Oct 25, 2016 20:03 pm UTC| Business
CORTLAND, Ohio, Oct. 25, 2016 -- Cortland Bancorp (OTCQX:CLDB), the holding company for Cortland Savings and Banking Company, today announced that its Board of Directors declared a quarterly cash dividend of $0.07 per...
Cortland Bancorp Declares Quarterly Cash Dividend of $0.07 Per Share
Oct 25, 2016 20:03 pm UTC| Business
CORTLAND, Ohio, Oct. 25, 2016 -- Cortland Bancorp (OTCQX:CLDB), the holding company for Cortland Savings and Banking Company, today announced that its Board of Directors declared a quarterly cash dividend of $0.07 per...
Vital Therapies Announces Upcoming Third Quarter Financial Results Conference Call With Webcast
Oct 25, 2016 20:03 pm UTC| Business
SAN DIEGO, Oct. 25, 2016 -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, will release its third quarter...